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Abstract
Background: Atopic dermatitis (AD) is a chronic, relapsing and pruritic inflammatory skin disease whose management
remains unclear to most non-dermatologists. This study aimed to assess the knowledge, attitudes and practices (KAP)
of the medical staff regarding AD in Yaoundé, Cameroon.
Methods: This was a cross-sectional study conducted from January to April 2014 in 20 health facilities located in
Yaoundé, the capital city of Cameroon. All medical staff who provided their consent were included in the study.
A score was established for each of the KAP categories, and subsequently grouped into 4 classes considering a
score <50, 50-<65, 65-<85 or ≥85%, respectively.
Results: We enrolled 100 medical personnel, 62% of whom were females. Overall, the level of knowledge on AD
was moderate (65%). Allergy was the main cause of AD, stated by 64% of participants. Only 43% personnel cited
the genetic cause. Asthma was mentioned by 78% as an associated pathology. Regarding attitudes, the majority
(84%) thought that AD is equally common among Black and Caucasian populations; 42% of participants believed
that evolution is favorable when appropriate medical treatment is prescribed. These attitudes were considered
wrong (64%). Similarly, the general level of practice was inadequate: 50%.
Conclusion: Levels of knowledge, attitudes and practices of the medical staff regarding AD were poor, implying
that management of this condition is non optimal in our setting.
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Background
Atopic Dermatitis (AD) is a chronic, relapsing and
pruritic inflammatory skin disease [1]. It is a condition
that predominantly affects children especially of a cer-
tain age, in developed countries and increasingly in the
developing world. An epidemiological study conducted
at the Yaoundé General Hospital (Cameroon) by Zoung-
Kanyi et al. found that allergic skin diseases were more
common in children aged 0–5 years with AD as the
leading one [2].
Onset of this condition occurs mostly in the first
months of life. Indeed, 60–70% of cases start before the
age of 6 months. Mesrati et al. in a pediatric dermatol-
ogy unit in Tunisia noticed that 7.5% of consultations
concerned AD [3], which contrasts with a prevalence of
10–25% reported in Western countries [4]. The young
and immature immunity of the child underlies this in-
creased susceptibility to outbreaks of AD, and conse-
quently the high prevalence of AD in this age group.
Indeed, AD is caused by defects in epidermal and cuta-
neous barriers which allow penetration of environmental
molecules in contact with the skin. This results in a
cutaneous inflammaxtion of which T-cells are respon-
sible, directed against environmental allergens (extrin-
sic AD) and/or cutaneous auto-antigens (intrinsic AD).
Moreover, AD can occur either in a context of atopy
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(predisposition to atopic states, known as extrinsic AD)
or not (intrinsic AD) [5].
Evolution of the disease remains difficult to appreci-
ate over years, although an improvement of signs is
observed in regularly monitored patients. In fact, AD is
usually characterized by surges and remissions at un-
predictable frequencies, varying from one person to
another with or without the influence of any driving
factor, making it difficult to infer on the final issue. Fol-
lowing the exponential increase in AD in both devel-
oped and developing countries, restructuring of various
aspects of its management has become essential to pre-
vent complications.
But prior to this restructuring, an assessment of the
knowledge and practices of the medical staff is mandatory,
which will identify their weaknesses and subsequently
enable improvement of their capacities. To the best of
our knowledge, no study has already assessed the
knowledge, attitudes and practices (KAP) of the medical
personnel towards AD in Cameroon, a developing coun-
try. With the ultimate goal of improving the manage-
ment of AD in Cameroonian hospitals, we undertook
the present study which purposed to assess the KAP of
medical professionals practicing in Yaoundé (Cameroon)
with respect to AD.
Methods
From January to April 2014, we conducted a cross-
sectional study including the medical staff practicing
in the city of Yaoundé. Five out of the seven existing
health districts of Yaoundé were selected for this
study and a total of 20 health facilities were visited.
The choice of health districts and health facilities was
arbitrary, taking into account the convenience for the
investigators and accessibility of health facilities. The
study population was comprised medical staff respon-
sible for consultations in the selected health facilities:
doctors (general practitioners and specialists/pediatri-
cians) and nurses. At each visit to the study sites, all
consulting staff irrespective of sex, seniority/experi-
ence, who consented to participate, were included.
Our sampling was consecutive throughout the study
period.
Before the study began, an ethical clearance was ob-
tained from the Ethical Review Board of the Faculty
of Medicine and Biomedical Sciences of the University
of Yaoundé I, Cameroon. Authorizations were equally
issued by health authorities of the selected health dis-
tricts as well as directors of selected health facilities.
The procedures were in compliance with the current
revision of Helsinki Declaration. All aspects and pro-
cedures of the study were fully presented to each
potential participant, and we included only those who
voluntarily signed the consent form. Anonymity of
participants and confidentiality of collected data were
respected.
This study used as reference model the international
consensus on management of AD [6]. An anonymous
pre-tested and standardized questionnaire was used for
data collection. All participants received the question-
naire to be filled; then the investigator returned on an
appointed day to retrieve the questionnaire, after en-
suring that this has been properly and extensively
completed. The questionnaire, in addition to questions
about age, gender, specialty and seniority in job/work
experience, consisted of a set of 45 questions divided
into three parts:
– Knowledge: theoretical clinical knowledge (primary
lesions, localization, associated pathologies, causes);
clinical knowledge based on recognition of
iconography (Additional file 1); knowledge on
prevention (information or advice to give to
patients/parents in order to prevent an AD
surge/relapse);
– Attitudes: perceptions of medical staff regarding the
frequency of AD (specifically depending on race),
evolution of AD with treatment, contribution of
relatives in AD management and capacity of medical
personnel to efficiently manage AD in our setting;
– Practice: number of cases of AD seen during
consultations, prescription given for surges/relapses,
route of administration of prescribed drugs,
frequency of drug administration and monitoring
of treatment.
The paper from Essi et al. on KAP studies [7] was used
to establish scores for each part of the questionnaire.
According to the sections (Knowledge, Attitudes, and
Practice), the categories are distributed as follows:
– Knowledge: very poor (score <50%); poor (score:
≥50 and <65%); moderate (score: ≥65 and <85%);
good (score ≥85%);
– Attitudes: harmful (score <50%); wrong (score: ≥50
and <65%); approximate (score: ≥65 and <85%);
right (score ≥85%);
– Practices: harmful (score <50%); inadequate (score:
≥50 and <65%); average (score: ≥65 and <85%);
adequate (score ≥85%).
Data were recorded and coded using Microsoft Excel
2007, then analyzed with SPSS v. 20 (IBM SPSS Inc.,
Chicago, Illinois, USA). Results are presented as frequency
(percentage) for categorical variables and mean ± standard
deviation (SD) for quantitative variables. To compare
qualitative variables, we used the chi-square test. The level
of statistical significance was set at p <0.05.
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Results
Characteristics of the study population
We included 100 participants, predominantly females
(62/100; 62.0%), giving a M/F sex ratio of 0.6/1. Our
sample consisted of specialists (40/100; 40%), namely
pediatric residents (20/100; 20%) and pediatricians (20/
100; 20%), general practitioners (38/100, 38%) and State




The majority of participants (75/100; 75%) were able to
accurately define AD (Table 1).
Associated pathologies
In our series, 78% (78/100) and 58% (58/100) respect-
ively thought that asthma and conjunctivitis can occur
in a patient with AD (Table 1).
Causes
Allergy was cited as the main cause of AD by 64% (64/100)
of our participants, and genetics by 43% (43/100) (Table 1).
Evolution
Most participants 77% (77/100) described AD as a chronic
disease; 54% (54/100) thought the condition is rather
acute and 46% (46/100) thought it is both acute and
chronic (Table 1).
Theoretical clinical knowledge
Primary lesions in AD
Concerning primary lesions of AD, the majority of health
care providers cited xerosis cutis (86%; 86/100), erythema
(81%; 81/100) and desquamation (58%; 58/100) as the
main signs observed in AD (Table 2).
Sites in infants and young adults
In infants (0–5 years old), participants declared that the
face (44/100; 44%) and torso (48/100; 48%) were the
most likely localizations for AD (Table 2). On the other
hand, the face (76/100; 76%) and trunk (58/100; 58%)
were declared not to be privileged sites of AD in young
adults (25–34 years old). Also, a little over half of par-
ticipants (59/100; 59%) believed the lower limbs were a
preferred site of AD lesions in adults (35 years old and
above) (Table 2).
Table 1 General knowledge of medical staff
Question Right response Number (%) Wrong response Number (%)
General knowledge (N = 100)
Definition
AD is chronic and inflammatory 75 (75) 25 (25)
AD is chronic or inflammatory 7 (7) 93 (93)
AD is inflammatory and acute 13 (13) 87 (87)
AD is inflammatory or acute 2 (2) 98 (98)
I do not know 3 (3) 97 (97)
Associated pathologies
Asthma is an associated pathology 78 (78) 22 (22)
Conjunctivitis is an associated pathology 58 (58) 42 (42)
Chronic cough is an associated pathology 16 (16) 84 (84)
There is no associated pathology 12 (12) 88 (88)
Causes
The cause is psychological 2 (2) 98 (98)
The cause is allergic 64 (64) 36 (36)
The cause is genetic 43 (43) 57 (57)
The cause is infectious 18 (18) 82 (82)
I do not know 5 (5) 95 (95)
Evolution (n = 100)
Evolution could be acute 54 (54) 46 (46)
Evolution could be chronic 77 (77) 23 (23)
Evolution is acute and chronic 46 (46) 54 (54)
Evolution is exclusively acute 1 (1) 99 (99)
Evolution is exclusively chronic 14 (14) 86 (86)
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Clinical knowledge based on iconography
Pictures 1 (80/100; 80%), 4 (75/100; 75%) and 5 (67/100;
67%) were selected for the diagnosis of AD while pictures
9 (15/100; 15%), 11 (15/100; 15%) and 13 (20/100; 20%)
were not (Additional file 1).
Prevention
The majority of participants (95/100; 95%) said they provide
patients with advice and information about prevention. Fur-
thermore, 91 (91) and 88 (88%) participants thought that
cotton clothing are recommended and a relapse requires a
new consultation, respectively.
Attitudes
Occurrence of AD based on race
AD is a disease that affects both Blacks and Caucasians
alike according to 84% (84/100) of the medical staff.
Opinion on evolution of AD
For 59% (59/100) of our sample, AD is a disease which
evolves towards complete remission when patients receive
the right treatment (Table 3).
Patient care by the relatives
A total of 42 participants (42%) thought that patients
could be taken care of by their relatives (Table 3).
Management in our setting
In our series, 85% (85/100) thought that management of
AD could be adequately provided in our setting (Table 3).
Practice
Of the 100 participants, 91% (91/100) reported having
encountered cases of AD during consultations. Table 4
shows their usual practice for every patient with this
pathology.
Half of our sample (51/100; 51%) said they had received
between 1 and 10 cases of AD per month at their consul-
tations while 25% (25/100) reported having consulted
more than 20 cases of AD.
Over half (79/100) of our sample chose to prescribe a
medication for a patient with AD.
When a patient came to consult for AD, 88% (88/100) of
the staff prescribed corticosteroids, most often topical (80/
83; 96.4%) and to be applied 2 times a day (46/88; 52.3%).
Management of xerosis cutis and pruritus
Xerosis cutis was supposed to be treated as declared by
81% (81/100) of the staff interviewed. For complaints of
pruritus, 90% (90/100) of participants prescribed anti-
histamines and frequently associated antihistamines
and corticosteroids, 63% (63/100) (Table 4).
Association of knowledge, attitudes and practices
of medical staff
Score of knowledge among medical staff
The level of knowledge was conditioned by experience
of the specialists. Indeed, more than half of pediatricians
had a moderate level of knowledge (14/20; 70%), while
50% of residents had a poor level of knowledge (10/20;
50%). General practitioners had poor to moderate levels
of knowledge about AD (Table 5).
Table 2 Clinical theoretical knowledge as medical personnel
Question Right response Number (%) Wrong response Number (%)
Theoritical clinical knowledge (n = 100)
Primary lesions
Xerosis cutis is a sign of AD 86 (86) 14 (14)
Erythema is a sign of AD 81 (81) 19 (19)
Desquamation is a sign of AD 58 (58) 42 (42)
Diffuse ulcerations is are signs of AD 17 (17) 83 (83)
Moist skin is a sign of AD 13 (13) 87 (87)
Cyanosis is a sign of AD 2 (2) 98 (98)
Sites in children (0–5 years old)
The face is a site of AD 44 (44) 56 (56)
The torso is a site of AD 48 (48) 52 (52)
The lower limb is a site of AD 32 (32) 68 (68)
Sites in adults (25 years old and above)
The face is a site of AD 24 (24) 76 (76)
The torso is a site of AD 42 (42) 58 (58)
The upper limb is a site of AD 79 (79) 21 (21)
The lower limb is a site of AD 41 (41) 59 (59)
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Score for attitudes among medical staff
Less than half (40/100) of pediatricians had a right attitude
towards AD, Fifty percent of pediatric residents had an ap-
proximate score, General practitioners had approximate
to harmful attitudes and nurses had approximate attitudes
in relation to AD (Table 5).
Score for practices among medical staff
Practices by all the professional categories were inadequate
(Table 5).
After making an overall score for each parameter
(knowledge, attitudes and practices), we observed that
the medical staff of Yaoundé had a moderate level of
knowledge (65%) with wrong attitudes (64%) and inad-
equate practices (50%) concerning AD.
Discussion
This study on AD enabled us to assess the knowledge of
medical professionals, their attitudes and clarify their
different practices. A total of 100 subjects agreed to an-
swer the questionnaire. Levels of knowledge, attitudes and
practices were respectively 65%, 64% and 50%. It clearly
appears thus that urgent measures need to be taken to
strengthen our medical staff capacities in order to improve
management of AD in Cameroonian hospital settings.
Knowledge of the medical staff
Overall, most of the medical personnel had already
heard about AD and was able to define it correctly. They
were also able to recognize the characteristic lesions of
the condition, probably as a result of their experience.
The most frequently mentioned cause of AD was allergy
(64%) in contrast to the genetic cause (43%). These re-
sults are significantly different from those found in the
Table 4 Practice of medical staff in case of AD relapses
Question Right Response Number (%)
Number ad cases seen during consultations (N = 100)
1-10 cases 51 (51)
11-20 cases 13 (13)
> 20 cases 25 (25)
No cases 11 (11)
*Drug prescription for ad relapse (N = 100)
Corticosteroids 88 (88)
Antihistamines (AH) 64 (64)
Antifungal 14 (14)
Antibiotics 12 (12)
Corticosteroids + AH 56 (56)
Management of xerosis cutis: yes 81 (81)
Drug prescription in case of pruritus
Antihistamines (AH) 90 (90)
Corticosteroids + AH 63 (63)
*Administration route of corticosteroids (N = 100)
Oral 17 (20.2)
Topical 80 (96.4)
Oral + Topical 12 (70.6)
Administration modalities of topical corticosteroids (n = 88)
1 application/day 38 (43.2)
2 applications/day 46 (52.3)
3 applications/day 4 (4.5)
Duration of the topical corticosteroid treatment (N = 100)
< 2 weeks 43 (43)
2 weeks 30 (30)
1 month 12 (12)
> 1 month 0 (0)
*More than one answer was possible
Table 3 Attitudes of medical personnel
Question Right response Number (%) Wrong response Number (%)
Opinion on occurrence of ad depending on race (N = 100)
AD mostly affects Blacks 3 (3) 97 (97)
AD equally affects Caucasians and Blacks 84 (84) 16 (16)
No idea 13 (13) 87 (87)
Opinion on the evolution of ad with treatment (N = 100)
Discouraging evolution 21 (21) 79 (79)
Favorable evolution 59 (59) 41 (41)
No idea 20 (20) 80 (80)
Opinion on contribution of relatives in management of ad (n = 100)
Discouraging contribution 28 (28) 72 (72)
Favorable contribution 42 (42) 58 (58)
No idea 30 (30) 70 (70)
Opinion on ability to adequately manage ad in our setting (N = 100)
AD can be managed 85 (85) 15 (15)
AD cannot be managed 7 (7) 93 (93)
No idea 8 (8) 92 (92)
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French national survey of professional practices on the
treatment of AD [8]. In this survey, the genetic cause
was indeed cited by almost all; regarding the allergic
cause, two sources were cited by the different categories
of professionals (allergists, dermatologists, general practi-
tioners and pediatricians), namely food and inhaled aller-
gens [8]. The psychological cause meanwhile was rarely
mentioned by those participating in our survey, which
mirrors findings from the French national survey indi-
cating that 80% of physicians rarely or never suggested a
psychological cause [8].
The medical staff demonstrated some confusion when
asked about chronicity of AD because 77% of the staff
declared that evolution could be chronic while 14% said
it was exclusively chronic. Furthermore, half of our
sample thought that this evolution could be acute. This
significant confusion could be explained by the fact that
in AD, the pruritic erythema is usually attributed to an
acute pathology.
The medical staff had average knowledge on preven-
tion. Pure cotton clothing was proposed by 90% of the
staff as a preventive method. This choice of clothing is
one of the recommendations of the 2005 consensus on
the management of AD in children [6]. Most often, the
staff believed a patient must return for consultation at
every relapse of AD (87%) while 15% thought that the
prescribed treatment would be sufficient to handle every
relapse. Also, 63% of participants declared that moisturiz-
ing body lotions were prescribed for prevention. Certainly
the 2005 consensus conference on the management of AD
is in favor of keeping the skin moisturized permanently;
however the medical professional must ensure that the
chosen lotion or cream is conducive for treatment of xero-
sis cutis [6]. Furthermore 54% of our participants encour-
aged the use of antiseptic solutions for baths which is in
contradiction with the 2013 consensus on AD, bolstering
that the use of antiseptics for baths is indicated only for
superinfected AD [9]. The moderate level of knowledge
on AD in our sample (65%) already predicted an inappro-
priate management of the condition. This can be justified
by the dearth of information on AD in our setting where
it is considered a foreign pathology.
Attitudes and practices of the medical staff
Half of our prescribers reported meeting between 1 and
10 cases of AD per month at consultations while only
25% had already received more than 20 cases/month.
This result is contrary to those from the French survey
where among various professional categories, 2 (pediatri-
cians and allergists) saw more than 30 cases per month
while only half of GPs (55%) saw less than 10 cases of
AD per month [8]. AD is a disease that equally affects
Blacks and Caucasians according to 84% of our sample,
a somewhat contradictory result given that only 54% said
they had not encountered many cases.
For 59% of our participants, AD usually has a favor-
able evolution when properly treated whereas 21% felt
the outcome is actually unfavorable. Yet, AD classically
involves intermittent periods of relapse and recovery
even when properly treated. Overall, the staff had wrong
attitude in relation to AD.
In case of AD relapses, our medical staff most frequently
said they prescribe corticosteroids; 80% of these partici-
pants chose a topical corticosteroid, which is higher than
those of the French study where dermatologists and gen-
eral practitioners generally prescribed topical corticoster-
oid as first-line treatment in 60% and 28% of cases,
respectively [8]. Moreover, in our study 56% reported pre-
scribing a corticosteroid and an antihistamine in case of
AD relapse but from the 2005 consensus conference on
the treatment of AD, antihistamines have no place in the
treatment of AD [6]. The 2013 consensus from the experts
recommends the use of sedating antihistamines in case of
intense pruritus [9].
Regarding the application of topical corticosteroid, half
of medical staff recommended 2 applications per day
while only 42% thought that the application of a topical
corticosteroid once daily would be sufficient. According to
Aubert et al., the use of corticosteroids differs depending
on symptomatic variations in the patient and should be
reasonable in order to avoid the risk of dependence or
Table 5 Scores of health care personnel according to the professional category
Consultant* Scores**
very poor/harmful/harmful poor/wrong/inadequate moderate/approximate/average good/right/adequate
K A P K A P K A P K A P
Pediatricians 0 (0) 0 (0) 4 (20) 4 (20) 6 (30) 16 (80) 14 (70) 6 (30) 0 (0) 2 (10) 8 (40) 0 (0)
Residents 0 (0) 4 (20) 5 (25) 10 (50) 5 (25) 15 (75) 9 (45) 10 (50) 0 (0) 2 (5) 1 (5) 0 (0)
General practitioners 1 (2.6) 10 (26.3) 15 (39.5) 18 (47.4) 12 (31.6) 23 (60.5) 18 (47.4) 10 (26.3) 0 (0) 0 (0) 6 (15.8) 0 (0)
Nurses 2 (9.1) 2 (9.1) 9 (41.0) 11 (50) 2 (9.1) 12 (54.5) 9 (45) 7 (31.8) 1 (4.5) 1 (0) 11 (50) 0 (0)
Total 3 (3) 16 (16) 33 (33) 43 (43) 25 (25) 66 (66) 50 (50) 33 (33) 1 (1) 4 n 26 (26) 0 (0)
*Figures represent the number (percentage); **The scores were classified into: very poor/harmful/harmful = less than 50%; poor/wrong/inadequate = less than 65%;
moderate/approximate/average = less than 85%; good/right/adequate =more than 85% correct answers; K = Knowledge; A = Attitude; P = Practice
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addiction [10]. Xerosis cutis is the sign in AD which
prompted prescription of a treatment in 81% of our
sample. Almost all prescribers said pruritus requires
prescription of an antihistamine. Also, a combination of
antihistamines and corticosteroids is systematic according
to 63% of participants, although the 2005 consensus on
AD states that administration of a topical corticosteroid
alone would be effective because of its antipruritic and
anti-inflammatory properties [6]. Clearly, the medical
personnel adopted a poor practice in cases of AD most
probably influenced by the moderate knowledge and in-
adequate attitude towards the condition.
The non-random selection of health facilities and the
relatively small number of enrolled participants may consti-
tute limits to the generalization of our results. Furthermore,
many medical staff had not agreed to take part in this study
and some were absent during our multiple visits to the
facilities. Nevertheless, the use of the gradation developed
by Essi et al. [7] allowed us to have a clear idea of the level
of knowledge, attitudes and practices of our participants.
Conclusion
This study allowed us to point out the moderate level of
knowledge, wrong attitudes and inadequate practices of
medical staff consulting in Yaoundé as far as AD is con-
cerned, which suggests a poor quality of care delivered
to patients with AD in our milieu, and a move towards
emergence of complications. Management guidelines on
this condition must be created and made available to our
healthcare providers along with organization of regular
continuous medical education sessions for them. Larger
scale studies are needed throughout the country, to have a
more precise mapping of the level of knowledge, attitudes
and practices regarding AD in order to improve its
management locally.
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